Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for TKI-induced Diarrhea (ASPIDIA)
NCT02323516Phase 2Withdrawn
- Sponsor
- Centre François Baclesse
- Start
- Dec 2014
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of aspirin in diarrhea (2 arms), sponsored by Centre François Baclesse. Primary endpoint: Efficacy measured by the decrease in the intensity of diarrhea and / or anti-diarrheal consumption at 1 month. Planned start Dec 2014; status: withdrawn.
02
Drugs
aspirin
03
Conditions
diarrhea
Beyond the preview
Go deeper on NCT02323516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02323516.